118 related articles for article (PubMed ID: 38724178)
1. The concept of Sfrp1
Liu X; Zhang X; Liang J; Noble PW; Jiang D
Eur Respir J; 2024 May; 63(5):. PubMed ID: 38724178
[TBL] [Abstract][Full Text] [Related]
2. Lung disease: CXCR7 activation overrides lung fibrosis.
Cully M
Nat Rev Drug Discov; 2016 Mar; 15(3):160. PubMed ID: 26915452
[No Abstract] [Full Text] [Related]
3. Notch1 signaling in FIZZ1 induction of myofibroblast differentiation.
Liu T; Hu B; Choi YY; Chung M; Ullenbruch M; Yu H; Lowe JB; Phan SH
Am J Pathol; 2009 May; 174(5):1745-55. PubMed ID: 19349363
[TBL] [Abstract][Full Text] [Related]
4. Targeting of the pulmonary capillary vascular niche promotes lung alveolar repair and ameliorates fibrosis.
Cao Z; Lis R; Ginsberg M; Chavez D; Shido K; Rabbany SY; Fong GH; Sakmar TP; Rafii S; Ding BS
Nat Med; 2016 Feb; 22(2):154-62. PubMed ID: 26779814
[TBL] [Abstract][Full Text] [Related]
5. Sfrp1 inhibits lung fibroblast invasion during transition to injury-induced myofibroblasts.
Mayr CH; Sengupta A; Asgharpour S; Ansari M; Pestoni JC; Ogar P; Angelidis I; Liontos A; Rodriguez-Castillo JA; Lang NJ; Strunz M; Porras-Gonzalez D; Gerckens M; De Sadeleer LJ; Oehrle B; Viteri-Alvarez V; Fernandez IE; Tallquist M; Irmler M; Beckers J; Eickelberg O; Stoleriu GM; Behr J; Kneidinger N; Wuyts WA; Wasnick RM; Yildirim AÖ; Ahlbrecht K; Morty RE; Samakovlis C; Theis FJ; Burgstaller G; Schiller HB
Eur Respir J; 2024 Feb; 63(2):. PubMed ID: 38212077
[TBL] [Abstract][Full Text] [Related]
6. Overexpressed microRNA-140 inhibits pulmonary fibrosis in interstitial lung disease via the Wnt signaling pathway by downregulating osteoglycin.
Shi S; Li H
Am J Physiol Cell Physiol; 2020 Nov; 319(5):C895-C905. PubMed ID: 32755451
[TBL] [Abstract][Full Text] [Related]
7. Secreted frizzled-related protein 1 (SFRP1) protects fibroblasts from ceramide-induced apoptosis.
Han X; Amar S
J Biol Chem; 2004 Jan; 279(4):2832-40. PubMed ID: 14581477
[TBL] [Abstract][Full Text] [Related]
8. Matrix Biology Highlights.
Neill T; Zoeller J
Matrix Biol; 2015 Oct; 48():1-2. PubMed ID: 26603526
[No Abstract] [Full Text] [Related]
9. Dynamic decreased expression and hypermethylation of secreted frizzled-related protein 1 and 4 over the course of pulmonary fibrosis in mice.
Zhou J; Yi Z; Fu Q
Life Sci; 2019 Feb; 218():241-252. PubMed ID: 30586565
[TBL] [Abstract][Full Text] [Related]
10. Effects of Secreted frizzled-related protein 1 on inhibiting cardiac remodeling.
Wang H; Liu Y; Liang X; Yang G; Liu Y; Li F; Guo YT; Wang HJ; Liu HB; Chen L
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6270-6278. PubMed ID: 32572894
[TBL] [Abstract][Full Text] [Related]
11. Methionine aminopeptidase-2 as a selective target of myofibroblasts in pulmonary fibrosis.
Kass D; Bridges RS; Borczuk A; Greenberg S
Am J Respir Cell Mol Biol; 2007 Aug; 37(2):193-201. PubMed ID: 17446530
[TBL] [Abstract][Full Text] [Related]
12. Luciferase expression is driven by the promoter of fibroblast activation protein-α in murine pulmonary fibrosis.
Wenlong L; Leilei Y; Wei F; Yi C; Jing T; Lanzhi M; Bing L; Yang L; Shaoxia W; Qiuxia F; Zeliang C; Zengming Z
Biotechnol Lett; 2015 Sep; 37(9):1757-63. PubMed ID: 25994578
[TBL] [Abstract][Full Text] [Related]
13. Secreted frizzled related protein 1 is a target to improve fracture healing.
Gaur T; Wixted JJ; Hussain S; O'Connell SL; Morgan EF; Ayers DC; Komm BS; Bodine PV; Stein GS; Lian JB
J Cell Physiol; 2009 Jul; 220(1):174-81. PubMed ID: 19301255
[TBL] [Abstract][Full Text] [Related]
14. Keloid fibroblasts are more sensitive to Wnt3a treatment in terms of elevated cellular growth and fibronectin expression.
Chua AW; Gan SU; Ting Y; Fu Z; Lim CK; Song C; Sabapathy K; Phan TT
J Dermatol Sci; 2011 Dec; 64(3):199-209. PubMed ID: 22005028
[TBL] [Abstract][Full Text] [Related]
15. The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis.
Dees C; Schlottmann I; Funke R; Distler A; Palumbo-Zerr K; Zerr P; Lin NY; Beyer C; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2014 Jun; 73(6):1232-9. PubMed ID: 23698475
[TBL] [Abstract][Full Text] [Related]
16. Amphiregulin, an epidermal growth factor receptor ligand, plays an essential role in the pathogenesis of transforming growth factor-β-induced pulmonary fibrosis.
Zhou Y; Lee JY; Lee CM; Cho WK; Kang MJ; Koff JL; Yoon PO; Chae J; Park HO; Elias JA; Lee CG
J Biol Chem; 2012 Dec; 287(50):41991-2000. PubMed ID: 23086930
[TBL] [Abstract][Full Text] [Related]
17. SFRP1 Negatively Modulates Pyroptosis of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis: A Review.
Jiang P; Wei K; Chang C; Zhao J; Zhang R; Xu L; Jin Y; Xu L; Shi Y; Guo S; Schrodi SJ; He D
Front Immunol; 2022; 13():903475. PubMed ID: 35795672
[TBL] [Abstract][Full Text] [Related]
18. Local administration of liposomal-based Srpx2 gene therapy reverses pulmonary fibrosis by blockading fibroblast-to-myofibroblast transition.
Wang Q; Liu J; Hu Y; Pan T; Xu Y; Yu J; Xiong W; Zhou Q; Wang Y
Theranostics; 2021; 11(14):7110-7125. PubMed ID: 34093874
[TBL] [Abstract][Full Text] [Related]
19. Chemokine CCL1 as a therapeutic target for pulmonary fibrosis: comments on 'The chemokine CCL1 triggers an AMFR‒SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis'.
Liu S; Liu C; Hu Z; Xiao Y
J Mol Cell Biol; 2022 Feb; 14(1):. PubMed ID: 34940827
[No Abstract] [Full Text] [Related]
20. Gene expression profiling of pulmonary fibrosis identifies Twist1 as an antiapoptotic molecular "rectifier" of growth factor signaling.
Bridges RS; Kass D; Loh K; Glackin C; Borczuk AC; Greenberg S
Am J Pathol; 2009 Dec; 175(6):2351-61. PubMed ID: 19893041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
